Selected article for: "attack rate and final attack rate"

Author: Martin, C. J.; McDonald, S.; Luteijn, M.; Robertson, J.; Letton, W.
Title: A model framework for projecting the prevalence and impact of Long-COVID in the UK
  • Cord-id: dfj7yxef
  • Document date: 2021_5_20
  • ID: dfj7yxef
    Snippet: Background The objective of this paper is to model lost Quality Adjusted Life Years (QALYs) from symptoms arising from COVID-19 in the UK population, including symptoms of 'long-COVID'. The scope includes QALYs lost to symptoms, but not deaths, due to acute COVID-19 and long COVID. Methods The prevalence of symptomatic COVID-19, encompassing acute symptoms and long-COVID symptoms, was modelled using a decay function. Permanent injury as a result of COVID-19 infection, was modelled as a fixed pre
    Document: Background The objective of this paper is to model lost Quality Adjusted Life Years (QALYs) from symptoms arising from COVID-19 in the UK population, including symptoms of 'long-COVID'. The scope includes QALYs lost to symptoms, but not deaths, due to acute COVID-19 and long COVID. Methods The prevalence of symptomatic COVID-19, encompassing acute symptoms and long-COVID symptoms, was modelled using a decay function. Permanent injury as a result of COVID-19 infection, was modelled as a fixed prevalence. Both parts are combined to calculate QALY loss due to COVID-19 symptoms. Results Assuming a 60% final attack rate for SARS-CoV-2 infection in the population, we modelled 299,719 QALYs lost within 1 year of infection (90% due to symptomatic COVID-19 and 10% permanent injury) and 557,754 QALYs lost within 10 years of infection (49% due to symptomatic COVID-19 and 51% due to permanent injury). The UK Government willingness-to-pay to avoid these QALY losses would be {pound}17.9 billion and {pound}32.2 billion, respectively. Additionally, 90,143 people were subject to permanent injury from COVID-19 (0.14% of the population). Conclusion Given the ongoing development in information in this area, we present a model framework for calculating the health economic impacts of symptoms following SARS-CoV-2 infection. This model framework can aid in quantifying the adverse health impact of COVID-19, long COVID and permanent injury following COVID-19 in society and assist the proactive management of risk posed to health. Further research is needed using standardised measures of patient reported outcomes relevant to long COVID and applied at a population level.

    Search related documents:
    Co phrase search for related documents
    • active infection and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • active infection and acute symptom: 1
    • active infection and adjusted prevalence: 1, 2
    • active infection and long covid: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • active infection and long covid acute: 1, 2
    • active infection period and acute infection: 1
    • active infection period and long covid: 1, 2
    • acute infection and adjusted life: 1, 2, 3
    • acute infection and adjusted life years: 1
    • acute infection and adjusted prevalence: 1, 2, 3, 4, 5, 6
    • acute infection and long covid: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute infection and long covid acute: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute infection and long covid patient: 1, 2, 3, 4
    • acute infection and long covid report: 1, 2, 3
    • acute infection and long covid symptom: 1, 2, 3
    • acute respiratory distress syndrome and adequate planning: 1, 2
    • acute respiratory distress syndrome and adjusted life: 1, 2
    • acute respiratory distress syndrome and adjusted life years: 1, 2
    • acute respiratory distress syndrome and long covid: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25